Oxalic Acid

Oxalic Acid

SCHEMBL9613886

NC(CCCCN1C(=O)c2ccccc2C1=O)Cc1c[nH]c2ccccc12.O=C(O)C(=O)O

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.61
▸ TDP1 Q9NUW8 2/20 0.61
▸ KMT2A Q03164 6/20 0.57
▸ MEN1 O00255 5/20 0.57
▸ NPC1 O15118 2/20 0.57
▸ RAB9A P51151 2/20 0.57
▸ GAA P10253 2/20 0.57
▸ DNMT1 P26358 3/20 0.56
▸ CYP2C19 P33261 1/20 0.56
▸ DNMT3B Q9UBC3 1/20 0.56
▸ PKM P14618 1/20 0.56
▸ LMNA P02545 4/20 0.52
▸ KDM4E B2RXH2 2/20 0.52
▸ MPO P05164 1/20 0.52
▸ TSHR P16473 1/20 0.52
▸ BLM P54132 1/20 0.52
▸ PMP22 Q01453 1/20 0.52
▸ HIF1A Q16665 1/20 0.52
▸ STAT3 P40763 1/20 0.48
▸ HTR2A P28223 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9596924 0.94 MAPT (0.67) MAPTTDP1KMT2AMEN1NPC1
SCHEMBL9603353 0.79 HTR2A (0.48) MAPTTDP1KMT2AMEN1NPC1
SCHEMBL9596806 0.79 MAPT (0.51) MAPTTDP1KMT2AMEN1NPC1
SCHEMBL21225808 0.77 MAPT (0.90) MAPTTDP1KMT2AMEN1NPC1
Tryptophanol SCHEMBL5374423 0.76 KDM4E (0.68) MAPTKMT2AMEN1GAADNMT1
Tryptophanol SCHEMBL5374419 0.76 KDM4E (0.68) MAPTKMT2AMEN1GAADNMT1
SCHEMBL9517046 0.76 MAPT (0.54) MAPTTDP1KMT2AMEN1NPC1
SCHEMBL931918 0.75 KDM4E (0.66) MAPTKMT2AMEN1GAADNMT1
SCHEMBL31383386 0.75 KDM4E (0.66) MAPTKMT2AMEN1GAADNMT1
SCHEMBL735125 0.74 MAPT (1.00) MAPTTDP1KMT2AMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5126363-A Central nervous system disorders NOVO NORDISK A/S (DK) 1992-06-30 — — US disclosed
Send feedback